Cargando…
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study
BACKGROUND: The major drivers of cost-effectiveness for chronic obstructive pulmonary disease (COPD) therapies are the occurrence of exacerbations and deaths. Exacerbations, including acute and long-term events, can cause worsening of COPD and lead to an increased risk of further exacerbations, and...
Autores principales: | Rhodes, Kirsty, Jenkins, Martin, de Nigris, Enrico, Aurivillius, Magnus, Ouwens, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134588/ https://www.ncbi.nlm.nih.gov/pubmed/35614467 http://dx.doi.org/10.1186/s12874-022-01616-7 |
Ejemplares similares
-
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
por: Bafadhel, Mona, et al.
Publicado: (2022) -
Improvements in lung function with
budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler
versus dual therapies in patients with COPD: a sub-study of
the ETHOS trial
por: Rabe, Klaus F., et al.
Publicado: (2021) -
Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
por: Whittaker, Hannah, et al.
Publicado: (2022) -
Mortality in ETHOS: A Question of “Power”
por: Rogliani, Paola, et al.
Publicado: (2021) -
Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)